Welcome to our dedicated page for Morgan Stanley SEC filings (Ticker: MSTLW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Morgan Stanley's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Morgan Stanley's regulatory disclosures and financial reporting.
NALLY DENNIS M reported acquisition or exercise transactions in this Form 4 filing.
Morgan Stanley director Dennis M. Nally reported two stock-based compensation awards of Common Stock. On June 1, 2026, he received 345.304 shares as restricted stock units priced at $209.9594 per share under the Morgan Stanley Directors' Equity Capital Accumulation Plan.
He also received 1,309.777 deferred stock units under the same directors' plan in lieu of cash retainers. Both the restricted stock units and deferred stock units are convertible into shares of Common Stock on a 1-to-1 basis, reflecting routine equity compensation rather than open-market buying or selling.
NALLY DENNIS M reported acquisition or exercise transactions in this Form 4 filing.
Morgan Stanley director Dennis M. Nally reported two stock-based compensation awards of Common Stock. On June 1, 2026, he received 345.304 shares as restricted stock units priced at $209.9594 per share under the Morgan Stanley Directors' Equity Capital Accumulation Plan.
He also received 1,309.777 deferred stock units under the same directors' plan in lieu of cash retainers. Both the restricted stock units and deferred stock units are convertible into shares of Common Stock on a 1-to-1 basis, reflecting routine equity compensation rather than open-market buying or selling.
WILKINS RAYFORD JR reported acquisition or exercise transactions in this Form 4 filing.
Morgan Stanley director Rayford Wilkins Jr received an equity award of 1,309.777 restricted stock units, which are convertible into Common Stock on a 1-to-1 basis under the Morgan Stanley Directors' Equity Capital Accumulation Plan. The award was granted at $0.00 per share as compensation rather than an open-market purchase.
Following this grant, Wilkins directly holds 78,268.886 shares of Morgan Stanley Common Stock. No derivative option positions are reported in this filing, so the change reflects an increase in his direct equity stake through stock-based compensation.
WILKINS RAYFORD JR reported acquisition or exercise transactions in this Form 4 filing.
Morgan Stanley director Rayford Wilkins Jr received an equity award of 1,309.777 restricted stock units, which are convertible into Common Stock on a 1-to-1 basis under the Morgan Stanley Directors' Equity Capital Accumulation Plan. The award was granted at $0.00 per share as compensation rather than an open-market purchase.
Following this grant, Wilkins directly holds 78,268.886 shares of Morgan Stanley Common Stock. No derivative option positions are reported in this filing, so the change reflects an increase in his direct equity stake through stock-based compensation.
Morgan Stanley director Megan Butler reported routine equity compensation activity. She received a grant of 1,309.777 shares of Common Stock in the form of restricted stock units under the Morgan Stanley Directors' Equity Capital Accumulation Plan, at no cash cost. To cover taxes upon conversion of these stock units into shares, 190 shares were withheld at a price of $209.9594 per share, a tax-withholding disposition rather than an open-market sale. After these transactions, Butler directly holds 6,019.147 shares of Morgan Stanley common stock.
Morgan Stanley director Megan Butler reported routine equity compensation activity. She received a grant of 1,309.777 shares of Common Stock in the form of restricted stock units under the Morgan Stanley Directors' Equity Capital Accumulation Plan, at no cash cost. To cover taxes upon conversion of these stock units into shares, 190 shares were withheld at a price of $209.9594 per share, a tax-withholding disposition rather than an open-market sale. After these transactions, Butler directly holds 6,019.147 shares of Morgan Stanley common stock.
Morgan Stanley director Erika H. James received a grant of 1,309.777 restricted stock units under the Morgan Stanley Directors' Equity Capital Accumulation Plan. These units convert into Common Stock on a 1-for-1 basis and increase her direct holdings to 13,252.773 shares, reflecting equity-based compensation rather than an open-market purchase.
Morgan Stanley director Erika H. James received a grant of 1,309.777 restricted stock units under the Morgan Stanley Directors' Equity Capital Accumulation Plan. These units convert into Common Stock on a 1-for-1 basis and increase her direct holdings to 13,252.773 shares, reflecting equity-based compensation rather than an open-market purchase.
Morgan Stanley director Lynn J. Good received stock-based compensation awards in the form of common stock and stock units. On 2026-06-01, she acquired 273.862 shares of common stock at $209.9594 per share and 1,309.777 additional shares at no cash cost to her.
Footnotes explain these are restricted stock units and deferred stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan, each convertible into common stock on a 1-to-1 basis. These awards are compensation-related grants, not open-market share purchases.
Morgan Stanley director Lynn J. Good received stock-based compensation awards in the form of common stock and stock units. On 2026-06-01, she acquired 273.862 shares of common stock at $209.9594 per share and 1,309.777 additional shares at no cash cost to her.
Footnotes explain these are restricted stock units and deferred stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan, each convertible into common stock on a 1-to-1 basis. These awards are compensation-related grants, not open-market share purchases.
Morgan Stanley director Perry M. Traquina reported receiving stock-based compensation rather than trading shares in the market. On 2026-06-01, Traquina acquired 369.119 shares of Morgan Stanley common stock at $209.9594 per share as a grant.
A separate award of 1,309.777 deferred stock units was also reported at a price of $0.00, reflecting units granted in lieu of cash retainers for board service. Footnotes explain these are restricted and deferred stock units under the Morgan Stanley Directors' Equity Capital Accumulation Plan, each convertible into one share of common stock.
The filing characterizes both entries as grants or awards, not open-market purchases or sales, and shows Traquina holding 90,963.319 shares of common stock directly following one of the reported transactions.
Morgan Stanley director Perry M. Traquina reported receiving stock-based compensation rather than trading shares in the market. On 2026-06-01, Traquina acquired 369.119 shares of Morgan Stanley common stock at $209.9594 per share as a grant.
A separate award of 1,309.777 deferred stock units was also reported at a price of $0.00, reflecting units granted in lieu of cash retainers for board service. Footnotes explain these are restricted and deferred stock units under the Morgan Stanley Directors' Equity Capital Accumulation Plan, each convertible into one share of common stock.
The filing characterizes both entries as grants or awards, not open-market purchases or sales, and shows Traquina holding 90,963.319 shares of common stock directly following one of the reported transactions.
Morgan Stanley director Douglas L. Peterson reported two equity awards of Common Stock. On June 1, 2026, he acquired 273.862 shares at a grant value of $209.9594 per share, plus 1,309.777 deferred stock units granted in lieu of cash retainers, both under the Morgan Stanley Directors' Equity Capital Accumulation Plan.
Morgan Stanley director Douglas L. Peterson reported two equity awards of Common Stock. On June 1, 2026, he acquired 273.862 shares at a grant value of $209.9594 per share, plus 1,309.777 deferred stock units granted in lieu of cash retainers, both under the Morgan Stanley Directors' Equity Capital Accumulation Plan.
Miscik Judith A reported acquisition or exercise transactions in this Form 4 filing.
Morgan Stanley director Judith A. Miscik received a grant of 1,309.777 shares of Common Stock on June 1, 2026 as part of her director compensation. The award is in the form of restricted stock units under the Morgan Stanley Directors' Equity Capital Accumulation Plan, convertible into Common Stock on a 1-to-1 basis.
Following this grant, she directly holds a total of 66,494.080 shares of Morgan Stanley Common Stock. This filing reflects a compensation-related equity award rather than an open-market purchase or sale.
Miscik Judith A reported acquisition or exercise transactions in this Form 4 filing.
Morgan Stanley director Judith A. Miscik received a grant of 1,309.777 shares of Common Stock on June 1, 2026 as part of her director compensation. The award is in the form of restricted stock units under the Morgan Stanley Directors' Equity Capital Accumulation Plan, convertible into Common Stock on a 1-to-1 basis.
Following this grant, she directly holds a total of 66,494.080 shares of Morgan Stanley Common Stock. This filing reflects a compensation-related equity award rather than an open-market purchase or sale.
Morgan Stanley director Robert H. Herz reported an award of 1,309.777 shares of Common Stock on the company’s Form 4. The award was made at a stated price of $0.00 per share as a compensation-related grant rather than an open-market purchase.
The filing shows his directly held Common Stock position increasing to 102,562.562 shares following this transaction. A footnote explains that the grant consists of restricted stock units issued under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which convert into Common Stock on a 1-for-1 basis.
Morgan Stanley director Robert H. Herz reported an award of 1,309.777 shares of Common Stock on the company’s Form 4. The award was made at a stated price of $0.00 per share as a compensation-related grant rather than an open-market purchase.
The filing shows his directly held Common Stock position increasing to 102,562.562 shares following this transaction. A footnote explains that the grant consists of restricted stock units issued under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which convert into Common Stock on a 1-for-1 basis.
Leibowitz Shelley B reported acquisition or exercise transactions in this Form 4 filing.
Morgan Stanley director Shelley B. Leibowitz received an equity award of 1,309.777 shares of Common Stock. This was a grant with no cash price per share, bringing her direct holdings to 48,369.693 shares after the transaction. The award consists of restricted stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which are convertible into Common Stock on a one-for-one basis.
Leibowitz Shelley B reported acquisition or exercise transactions in this Form 4 filing.
Morgan Stanley director Shelley B. Leibowitz received an equity award of 1,309.777 shares of Common Stock. This was a grant with no cash price per share, bringing her direct holdings to 48,369.693 shares after the transaction. The award consists of restricted stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which are convertible into Common Stock on a one-for-one basis.